PARACETAMOL Side Effects

6918330-8 | Hypotension
on Jul 28, 2010 Male patient from FRANCE , 71 years of age, was diagnosed with pyrexia and was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Paracetamol dosage: 1 G, Unk.

6915677-6 | Oesophageal Perforation
Patient was taking Paracetamol (View Usage). Patient had the following side effects: oesophageal perforation on May 11, 2010 from GERMANY Additional patient health information: Female patient , 41 years of age, . Paracetamol dosage: . Patient was hospitalized.

6915629-6 | Acidosis, Alanine Aminotransferase Increased, Atrial Fibrillation, Hepatic Necrosis, Overdose, Vomiting
Adverse event was reported on May 13, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 2 Df, Qid) was diagnosed with pain (What is pain?), pneumonia (What is pneumonia?), cardiac failure, alcohol withdrawal syndrome and. Location: UNITED KINGDOM , 86 years of age, After Paracetamol was administered, patient had the following side effects: acidosis, alanine aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), hepatic necrosis, overdose, vomiting. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (2 Df, Qid) (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), PENICILLIN G (1 Df, Qid) (View Penicillin G Review and Penicillin G Label ), BISOPROLOL (2.5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), BUMETANIDE (2 Mg, Unk) (View Bumetanide Review and Bumetanide Label ), CHLORDIAZEPOXIDE (20 Mg, Qid) (View Chlordiazepoxide Review and Chlordiazepoxide Label ), CYCLIZINE (50 Mg, Qd) (View Cyclizine Review and Cyclizine Label ). Patient was hospitalized.

6910291-0 | Hypertransaminasaemia
on Jul 23, 2010 Female patient from GERMANY , 61 years of age, weighting 151.0 lb, was diagnosed with pain in extremity, hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?), prophylaxis against gastrointestinal ulcer, hypertension, chronic obstructive pulmonary disease and was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hypertransaminasaemia. Paracetamol dosage: 1000 Mg, Qd. During the same period patient was treated with EZETIMIBE/SIMVASTATIN (1 Df, Qd) (View Ezetimibe/simvastatin Review and Ezetimibe/simvastatin Label ), FALITHROM (3 Mg, Qd) (View Falithrom Review and Falithrom Label ), CONCOR (7.5 Mg, Bid) (View Concor Review and Concor Label ), DIGITOXIN (0.07 Mg, Qd) (View Digitoxin Review and Digitoxin Label ), PANTOZOL (40 Mg, Bid) (View Pantozol Review and Pantozol Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ), SPIRIVA (18 Ug, Qd) (View Spiriva Review and Spiriva Label ). Patient was hospitalized.


6910289-2 | Hypersensitivity
on Jul 23, 2010 Male patient from GERMANY , 60 years of age, weighting 121.3 lb, was diagnosed with viral upper respiratory tract infection, limb discomfort and was treated with Paracetamol (View Usage). Patient had the following side effects: hypersensitivity. Paracetamol dosage: 500 Mg, Unk. During the same period patient was treated with DICLOFENAC (Unk) (View Diclofenac Review and Diclofenac Label ). Patient was hospitalized.

6899577-6 | Confusional State, Hallucination, Auditory, Overdose, Sedation
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: confusional state, hallucination, auditory, overdose, sedation on Jul 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 31 years of age, was diagnosed with schizophrenia and. Paracetamol dosage: Unk. During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ). Patient was hospitalized.

6894183-1 | Agitation, Dry Mouth, Thirst
Adverse event was reported on Jul 14, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: 1 G, Qid) was diagnosed with back pain (What is back pain?) and. Location: UNITED KINGDOM , 58 years of age, Patient experienced the following unwanted or unexpected effects: agitation, dry mouth, thirst. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (1 Df, Bid) (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), LEVOTHYROXINE SODIUM (75 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6894014-X | Ataxia, Dysarthria, Ischaemic Stroke, Saccadic Eye Movement
on Jul 13, 2010 Female patient from JAPAN , 32 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: ataxia (What is ataxia?), dysarthria, ischaemic stroke, saccadic eye movement. Paracetamol dosage: 900 Mg, Unk. During the same period patient was treated with DIHYDROCODEINE BITARTRATE INJ (24 Mg, Unk) (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), CLEMASTINE FUMARATE (1.34 Mg, Unk) (View Clemastine Fumarate Review and Clemastine Fumarate Label ), LYSOZYME CHLORIDE (90 Mg, Unk) (View Lysozyme Chloride Review and Lysozyme Chloride Label ), ATROPA BELLADONNA (0.3 Mg, Unk) (View Atropa Belladonna Review and Atropa Belladonna Label ), NOSCAPINE (48 Mg, Unk) (View Noscapine Review and Noscapine Label ), METHYLEPHEDRINE HYDROCHLORIDE (60 Mg, Unk) (View Methylephedrine Hydrochloride Review and Methylephedrine Hydrochloride Label ), CAFFEINE (75 Mg, Unk) (View Caffeine Review and Caffeine Label ), BENFOTIAMINE (24 Mg, Unk) (View Benfotiamine Review and Benfotiamine Label ).

6883946-4 | Acute Respiratory Distress Syndrome, Agitation, Alanine Aminotransferase Increased, Blood Bilirubin Increased, Confusional State, Depressed Level Of Consciousness, Hypoglycaemia, International Normalised Ratio Increased
on Jul 15, 2010 Male patient from UNITED KINGDOM , 55 years of age, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: acute respiratory distress syndrome, agitation, alanine aminotransferase increased, blood bilirubin increased, confusional state, depressed level of consciousness, hypoglycaemia, international normalised ratio increased. Paracetamol dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CINNARIZINE (View Cinnarizine Review and Cinnarizine Label ). Patient was hospitalized.

6881762-0 | Accidental Overdose, Grand Mal Convulsion, Hyponatraemia
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, grand mal convulsion, hyponatraemia on Jul 15, 2010 from SPAIN Additional patient health information: Female patient , weighting 10.36 lb, was diagnosed with pyrexia and. Paracetamol dosage: 500 Mg, Unk. During the same period patient was treated with ACETYLCYSTEINE (150 Mg/kg, Unk) (View Acetylcysteine Review and Acetylcysteine Label ), DEXTROSE (950 Ml, Unk) (View Dextrose Review and Dextrose Label ). Patient was hospitalized.

6875536-4 | Acute Hepatic Failure
Adverse event was reported on Jul 21, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 42 years of age, weighting 154.3 lb, Patient had the following side effects: acute hepatic failure. Patient was hospitalized.

6875467-X | Liver Injury
on Jul 14, 2010 Female patient from UNITED KINGDOM , child 5 years of age, weighting 38.58 lb, was diagnosed with pyrexia, influenza like illness and was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: liver injury. Paracetamol dosage: . During the same period patient was treated with ASPIRIN (324 Mg Every 4-8 Hours) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6875464-4 | Acute Hepatic Failure
on Jul 15, 2010 Male patient from UNITED KINGDOM , 20 years of age, weighting 99.21 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure. Paracetamol dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6871117-7 | Anaphylactoid Reaction, Bradycardia, Brain Injury, Bronchospasm, Cardiac Arrest, Cyanosis, Dyspnoea, Hypoxic-ischaemic Encephalopathy, Intentional Overdose
Patient was taking Paracetamol (View Usage). Patient had the following side effects: anaphylactoid reaction, bradycardia, brain injury, bronchospasm, cardiac arrest (What is cardiac arrest?), cyanosis, dyspnoea, hypoxic-ischaemic encephalopathy, intentional overdose on Jul 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 40 years of age, weighting 222.7 lb, was diagnosed with intentional overdose, depression (What is depression?), asthma (What is asthma?) and. Paracetamol dosage: 15 G, Unk. During the same period patient was treated with ACETYLCYSTEINE (150 Mg/kg, Unk) (View Acetylcysteine Review and Acetylcysteine Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (60 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), TERBUTALINE SULFATE (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ). Patient was hospitalized.

6871097-4 | Liver Function Test Abnormal, Liver Injury
Adverse event was reported on Jul 09, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 1 G, Qid) was diagnosed with procedural pain, prophylaxis and. Location: UNITED KINGDOM , 21 years of age, weighting 88.18 lb, After Paracetamol was administered, patient had the following side effects: liver function test abnormal, liver injury. During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (Unk) (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), RANITIDINE (50 Mg, Unk) (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6866261-4 | Confusional State, Hallucination, Auditory, Sedation
on Jul 13, 2010 Male patient from UNITED KINGDOM , 31 years of age, was diagnosed with schizophrenia and was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, hallucination, auditory, sedation. Paracetamol dosage: . During the same period patient was treated with ZAPONEX (View Zaponex Review and Zaponex Label ). Patient was hospitalized.

6863035-5 | Liver Function Test Abnormal, Liver Injury
on Jul 08, 2010 Male patient from UNITED KINGDOM , 21 years of age, weighting 88.18 lb, was diagnosed with procedural pain, prophylaxis and was treated with Paracetamol (View Usage). Patient had the following side effects: liver function test abnormal, liver injury. Paracetamol dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6862042-6 | Hypernatraemia
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: hypernatraemia on Jul 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 89 years of age, was diagnosed with back pain (What is back pain?), metastases to spine and. Paracetamol dosage: 1 G, Qid. During the same period patient was treated with CYPROTERONE ACETATE (View Cyproterone Acetate Review and Cyproterone Acetate Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), GOSERELIN (View Goserelin Review and Goserelin Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

6855811-X | Acute Hepatic Failure, Hepatorenal Syndrome, Renal Failure Acute
Adverse event was reported on Jul 05, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: Unk) was diagnosed with pyrexia and. Location: GERMANY , 27 years of age, weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: acute hepatic failure, hepatorenal syndrome, renal failure acute.

6794515-9 | Erythema Multiforme
on Jun 11, 2010 Male patient from SPAIN , child 11 years of age, was diagnosed with nasopharyngitis and was treated with Paracetamol (View Usage). Patient had the following side effects: erythema multiforme. Paracetamol dosage: 500 Mg, Unk. During the same period patient was treated with TERMALGIN (View Termalgin Review and Termalgin Label ), ANTALGIN (View Antalgin Review and Antalgin Label ), DIPYRONE (View Dipyrone Review and Dipyrone Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6790329-4 | Blood Creatinine Increased, Pneumonia, Urinary Retention
on Jan 22, 2008 Male patient from UNITED KINGDOM , weighting 196.2 lb, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: blood creatinine increased, pneumonia (What is pneumonia?), urinary retention. Paracetamol dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6766641-1 | Erythema Multiforme
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme on May 28, 2010 from SPAIN Additional patient health information: Female patient , 43 years of age, . Paracetamol dosage: . Patient was hospitalized.

6765317-4 | Acute Hepatic Failure, Circulatory Collapse, Hepatic Encephalopathy, Overdose
Adverse event was reported on May 28, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 31 years of age, Patient had the following side effects: acute hepatic failure, circulatory collapse, hepatic encephalopathy, overdose. Patient was hospitalized.

6762262-5 | Toxic Epidermal Necrolysis
on May 28, 2010 Female patient from NETHERLANDS , 29 years of age, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: toxic epidermal necrolysis. Paracetamol dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), DIHYDROERGOTAMINE (View Dihydroergotamine Review and Dihydroergotamine Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), GLAFENINE (View Glafenine Review and Glafenine Label ). Patient was hospitalized.

6762261-3 | Toxic Epidermal Necrolysis
on May 28, 2010 Female patient from NETHERLANDS , 73 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Paracetamol dosage: . During the same period patient was treated with CHLORMEZANONE (View Chlormezanone Review and Chlormezanone Label ), PROPYPHENAZONE (View Propyphenazone Review and Propyphenazone Label ). Patient was hospitalized.

6762260-1 | Sepsis, Toxic Epidermal Necrolysis
Patient was taking Paracetamol (View Usage). Patient had the following side effects: sepsis (What is sepsis?), toxic epidermal necrolysis on May 28, 2010 from NETHERLANDS Additional patient health information: Male patient , 52 years of age, . Paracetamol dosage: . During the same period patient was treated with INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), CHLORMEZANONE (View Chlormezanone Review and Chlormezanone Label ). Patient was hospitalized.

6761133-8 | Toxic Epidermal Necrolysis
Adverse event was reported on May 24, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: ) . Location: SPAIN , 24 years of age, After Paracetamol was administered, patient had the following side effects: toxic epidermal necrolysis. During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ).

6758825-3 | Toxic Epidermal Necrolysis
on May 24, 2010 Female patient from SPAIN , 24 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Paracetamol dosage: . During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ).

6755835-7 | Conjunctivitis, Staphylococcal Infection, Stomatitis, Toxic Epidermal Necrolysis, Vulvitis
on May 24, 2010 Female patient from NETHERLANDS , 34 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: conjunctivitis, staphylococcal infection (What is staphylococcal infection?), stomatitis, toxic epidermal necrolysis, vulvitis. Paracetamol dosage: . Patient was hospitalized.

6755831-X | Toxic Epidermal Necrolysis
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: toxic epidermal necrolysis on May 24, 2010 from NETHERLANDS Additional patient health information: Female patient , 70 years of age, . Paracetamol dosage: . Patient was hospitalized.

6755475-X | Toxic Epidermal Necrolysis
Adverse event was reported on May 24, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: ) . Location: FRANCE , 87 years of age, Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis.

6754293-6 | Toxic Epidermal Necrolysis
on May 24, 2010 Female patient from FRANCE , 54 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Paracetamol dosage: .

6754131-1 | Toxic Epidermal Necrolysis
on May 24, 2010 Female patient from ITALY , 19 years of age, was diagnosed with tension headache and was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: toxic epidermal necrolysis. Paracetamol dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NIMESULIDE (View Nimesulide Review and Nimesulide Label ). Patient was hospitalized.

6752945-5 | Acute Hepatic Failure, Encephalopathy, Hepatitis Toxic, Prothrombin Time Abnormal
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, encephalopathy, hepatitis toxic, prothrombin time abnormal on May 20, 2010 from SWITZERLAND Additional patient health information: Female patient , 54 years of age, . Paracetamol dosage: . Patient was hospitalized.

6752210-6 | Circulatory Collapse, Hepatic Failure, Overdose
Adverse event was reported on May 24, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: ) . Location: BELGIUM , 31 years of age, Patient had the following side effects: circulatory collapse, hepatic failure, overdose. Patient was hospitalized.

6735064-3 | Rhabdomyolysis
on May 10, 2010 Female patient from UNITED KINGDOM , 19 years of age, was diagnosed with intentional overdose and was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: rhabdomyolysis. Paracetamol dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), NYTOL (View Nytol Review and Nytol Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), ALCOHOL (View Alcohol Review and Alcohol Label ).

6732616-1 | Circulatory Collapse, Hepatic Failure, Overdose
on May 17, 2010 Female patient from BELGIUM , 31 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, hepatic failure, overdose. Paracetamol dosage: . Patient was hospitalized.

6725120-8 | Abdominal Pain, Intentional Overdose, Nausea
Patient was taking Paracetamol (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), intentional overdose, nausea (What is nausea?) on Apr 30, 2010 from TURKEY Additional patient health information: Female patient , 16 years of age, was diagnosed with suicide attempt and. Paracetamol dosage: 8 G, Unk. During the same period patient was treated with AMOXICILLIN (3.5 G, Unk) (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6723076-5 | Acidosis, Alanine Aminotransferase Increased, Atrial Fibrillation, Hepatic Necrosis, Overdose, Vomiting
Adverse event was reported on Apr 29, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 2 Df, Qid) was diagnosed with pain (What is pain?), pneumonia (What is pneumonia?), cardiac failure, alcohol withdrawal syndrome and. Location: UNITED KINGDOM , 86 years of age, After Paracetamol was administered, patient had the following side effects: acidosis, alanine aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), hepatic necrosis, overdose, vomiting. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (2 Df, Qid) (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), BENZYLPENICILLIN (1 Df, Qid) (View Benzylpenicillin Review and Benzylpenicillin Label ), BISOPROLOL (2.5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), BUMETANIDE (2 Mg, Unk) (View Bumetanide Review and Bumetanide Label ), CHLORDIAZEPOXIDE (20 Mg, Qid) (View Chlordiazepoxide Review and Chlordiazepoxide Label ), CODEINE SULFATE (30 Mg, Qd) (View Codeine Sulfate Review and Codeine Sulfate Label ), CYCLIZINE (50 Mg, Qd) (View Cyclizine Review and Cyclizine Label ). Patient was hospitalized.

6720902-0 | Dehydration, Depressed Level Of Consciousness, Hyperglycaemia, Intentional Overdose, Ketonuria, Metabolic Acidosis, Nystagmus, Polyuria, Shock
on Apr 30, 2010 Male patient from UNITED KINGDOM , 37 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, depressed level of consciousness, hyperglycaemia, intentional overdose, ketonuria, metabolic acidosis, nystagmus, polyuria, shock. Paracetamol dosage: . During the same period patient was treated with ALCOHOL (WINE) (View Alcohol (wine) Review and Alcohol (wine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENZODIAZEPINES NOS (View Benzodiazepines Nos Review and Benzodiazepines Nos Label ). Patient was hospitalized.

6716839-3 | Acidosis, Alanine Aminotransferase Increased, Atrial Fibrillation, Hepatic Necrosis, Vomiting
on Apr 27, 2010 Male patient from UNITED KINGDOM , 86 years of age, was diagnosed with pain (What is pain?), pneumonia (What is pneumonia?), cardiac failure, alcohol withdrawal syndrome, atrial fibrillation (What is atrial fibrillation?) and was treated with Paracetamol (View Usage). Patient had the following side effects: acidosis, alanine aminotransferase increased, atrial fibrillation (What is atrial fibrillation?), hepatic necrosis, vomiting. Paracetamol dosage: 2 Df, Qid. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (2 Df, Qid) (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), BENZYLPENICILLIN (1 Df, Qid) (View Benzylpenicillin Review and Benzylpenicillin Label ), BISOPROLOL (2.5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), BUMETANIDE (2 Mg, Unk) (View Bumetanide Review and Bumetanide Label ), CHLORDIAZEPOXIDE (20 Mg, Qid) (View Chlordiazepoxide Review and Chlordiazepoxide Label ), CODEINE SULFATE (30 Mg, Qd) (View Codeine Sulfate Review and Codeine Sulfate Label ), CYCLIZINE (50 Mg, Qd) (View Cyclizine Review and Cyclizine Label ), DIGOXIN (125 Ug, Qd) (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6711399-5 | Dehydration, Depressed Level Of Consciousness, Hyperglycaemia, Intentional Overdose, Ketonuria, Metabolic Acidosis, Nystagmus, Polyuria, Shock
Patient was taking Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: dehydration, depressed level of consciousness, hyperglycaemia, intentional overdose, ketonuria, metabolic acidosis, nystagmus, polyuria, shock on Apr 27, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 37 years of age, . Paracetamol dosage: . During the same period patient was treated with ALCOHOL (WINE) (View Alcohol (wine) Review and Alcohol (wine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENZODIAZEPINES NOS (View Benzodiazepines Nos Review and Benzodiazepines Nos Label ). Patient was hospitalized.

6703283-8 | Acute Pulmonary Oedema, Hepatic Failure, Overdose, Renal Failure
Adverse event was reported on Apr 16, 2010 by a Female patient taking Paracetamol (View Usage) (Dosage: 30 G, Unk) . Location: FRANCE , 33 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, hepatic failure, overdose, renal failure. Patient was hospitalized.

6703206-1 | Blood Potassium Decreased, Liver Disorder, Overdose
on Apr 19, 2010 Female patient from UNITED KINGDOM , 51 years of age, was treated with Paracetamol (View Usage). Patient had the following side effects: blood potassium decreased, liver disorder, overdose. Paracetamol dosage: . During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ). Patient was hospitalized.

6701422-6 | Hepatic Failure, Overdose, Renal Failure
on Apr 16, 2010 Female patient from FRANCE , 17 years of age, weighting 123.5 lb, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: hepatic failure, overdose, renal failure. Paracetamol dosage: 19 G, Unk.

6701420-2 | Hepatic Failure, Overdose, Renal Failure
Patient was taking Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, overdose, renal failure on Apr 16, 2010 from FRANCE Additional patient health information: Female patient , 46 years of age, weighting 152.1 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and. Paracetamol dosage: 32 G, Unk. During the same period patient was treated with CODEINE SULFATE (View Codeine Sulfate Review and Codeine Sulfate Label ). Patient was hospitalized.

6699853-6 | Hepatitis Acute
Adverse event was reported on Apr 14, 2010 by a Male patient taking Paracetamol (View Usage) (Dosage: 500 Mg, Unk) was diagnosed with depression (What is depression?), parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , 56 years of age, weighting 163.1 lb, Patient had the following side effects: hepatitis acute. During the same period patient was treated with CIPROBAY, 250MG, FILMTABL, BAYER (250 Mg, Bid) (View Ciprobay, 250mg, Filmtabl, Bayer Review and Ciprobay, 250mg, Filmtabl, Bayer Label ), REMERGIL SOLTAB, 15/30 MG, SCHMELZTABL, ORGANON (Unk) (View Remergil Soltab, 15/30 Mg, Schmelztabl, Organon Review and Remergil Soltab, 15/30 Mg, Schmelztabl, Organon Label ), FLUOXETIN, 20MG, TABL (20 Mg, Qd) (View Fluoxetin, 20mg, Tabl Review and Fluoxetin, 20mg, Tabl Label ), ENAHEXAL, 10MG, TABL, HEXAL (Unk) (View Enahexal, 10mg, Tabl, Hexal Review and Enahexal, 10mg, Tabl, Hexal Label ), PANTOZOL, 40 MG, TABL, NYCOMED (40 Mg, Qd) (View Pantozol, 40 Mg, Tabl, Nycomed Review and Pantozol, 40 Mg, Tabl, Nycomed Label ), REQUIP, 0.25 MG, FILMTABL, GSK (Unk) (View Requip, 0.25 Mg, Filmtabl, Gsk Review and Requip, 0.25 Mg, Filmtabl, Gsk Label ), TAVOR/TAVOR EXPIDET, TABL/TAFELCHEN, WYETH (Unk) (View Tavor/tavor Expidet, Tabl/tafelchen, Wyeth Review and Tavor/tavor Expidet, Tabl/tafelchen, Wyeth Label ), IBUHEXAL, 400 MG FILMTABL, HEXAL (400 Mg, Unk) (View Ibuhexal, 400 Mg Filmtabl, Hexal Review and Ibuhexal, 400 Mg Filmtabl, Hexal Label ). Patient was hospitalized.

6693655-2 | Acute Hepatic Failure, Circulatory Collapse, Hepatic Encephalopathy, Overdose
on Apr 09, 2010 Female patient from UNITED KINGDOM , 31 years of age, was treated with Paracetamol (View Usage). After Paracetamol was administered, patient had the following side effects: acute hepatic failure, circulatory collapse, hepatic encephalopathy, overdose. Paracetamol dosage: . Patient was hospitalized.

6691874-2 | Circulatory Collapse, Hepatic Failure, Overdose
on Apr 15, 2010 Female patient from BELGIUM , 31 years of age, was treated with Paracetamol (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, hepatic failure, overdose. Paracetamol dosage: . Patient was hospitalized.

6691872-9 | Chest Discomfort, Depressed Level Of Consciousness, Electrocardiogram Change, Vomiting
Patient was taking Paracetamol (View Usage). Patient had the following side effects: chest discomfort, depressed level of consciousness, electrocardiogram change, vomiting on Apr 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 16 years of age, was diagnosed with intentional overdose and. Paracetamol dosage: . During the same period patient was treated with FLECAINIDE (View Flecainide Review and Flecainide Label ), CODEINE (View Codeine Review and Codeine Label ). Patient was hospitalized.